Darya-Varia Laboratoria Tbk PT
IDX:DVLA

Watchlist Manager
Darya-Varia Laboratoria Tbk PT Logo
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
Watchlist
Price: 1 615 IDR -0.31% Market Closed
Market Cap: 1.8T IDR
Have any thoughts about
Darya-Varia Laboratoria Tbk PT?
Write Note

Darya-Varia Laboratoria Tbk PT
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Darya-Varia Laboratoria Tbk PT
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
Net Income (Common)
Rp193.9B
CAGR 3-Years
-12%
CAGR 5-Years
-2%
CAGR 10-Years
6%
T
Tempo Scan Pacific Tbk PT
IDX:TSPC
Net Income (Common)
Rp1.3T
CAGR 3-Years
16%
CAGR 5-Years
21%
CAGR 10-Years
8%
Kalbe Farma Tbk PT
IDX:KLBF
Net Income (Common)
Rp3.1T
CAGR 3-Years
1%
CAGR 5-Years
4%
CAGR 10-Years
4%
Soho Global Health Tbk PT
IDX:SOHO
Net Income (Common)
Rp371.3B
CAGR 3-Years
29%
CAGR 5-Years
50%
CAGR 10-Years
N/A
Pyridam Farma Tbk PT
IDX:PYFA
Net Income (Common)
-Rp254B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Kimia Farma Tbk PT
IDX:KAEF
Net Income (Common)
-Rp1.7T
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Darya-Varia Laboratoria Tbk PT
Glance View

Market Cap
1.8T IDR
Industry
Pharmaceuticals

PT Darya-Varia Laboratoria Tbk engages in the manufacture and trade of pharmaceutical products and cosmetics. The company is headquartered in Jakarta, Dki Jakarta and currently employs 1,274 full-time employees. Its segments include prescription drugs, consumer health products, and export and toll manufacturing services. The firm provides products and services for consumer health, skin nutrition, respiratory, vitamins and daily relief. The Company’s products include Remscar (silicone gel), Carvilol, Ondavar (antiemetic), Etorix, Forti-D (vitamin D supplement), Decolgen, Neozep, Stop Cold, Decolsin, and Allerin. The Carvilol is used for heart health and treating hypertension. Ondavar is an antiemetic product used for nausea and vomiting during pregnancy. Etorix is a pain reliever. Forti-D is a supplement to fulfill the body’s need for vitamin D3. Darya-Varia provides a range of brands such as Enervon-C, Enervon Active, and Supertin that helps to boost body immune and maintain health. The firm also provides Imunped as supplement for kids with Zinc and vitamin C for children.

DVLA Intrinsic Value
2 159.17 IDR
Undervaluation 25%
Intrinsic Value
Price

See Also

What is Darya-Varia Laboratoria Tbk PT's Net Income (Common)?
Net Income (Common)
193.9B IDR

Based on the financial report for Sep 30, 2024, Darya-Varia Laboratoria Tbk PT's Net Income (Common) amounts to 193.9B IDR.

What is Darya-Varia Laboratoria Tbk PT's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
6%

Over the last year, the Net Income (Common) growth was 131%. The average annual Net Income (Common) growth rates for Darya-Varia Laboratoria Tbk PT have been -12% over the past three years , -2% over the past five years , and 6% over the past ten years .

Back to Top